Healthcare -
Biotechnology - NASDAQ - US
$ 46.75
-26.6 %
$ 4.59 B
Market Cap
19.98
P/E
SRPT - REVENUE
Revenue SRPT - Sarepta Therapeutics, Inc.
1.9 B
LAST VALUE
42.78%
2 YEAR CAGR
37.94%
5 YEAR CAGR
69.43%
10 YEAR CAGR